3P Biopharmaceuticals participates in an International Symposium on advances in vaccine development

Edita Mistiniene, R&D Director of 3P, talked about the role of a CMO in bringing products from the research lab to the market in time-efficient way

3P Biopharmaceuticals participated in an International Symposium on advances in vaccine development organized by CIMA (the Center for Applied Medical Research at the University of Navarre in Pamplona, Spain) on 25 and 26 October. Over the course of the twoday symposium, more than 60 specialists met to share information on the latest advances in vaccine development.

Edita Mistiniene, R&D Director of 3P, closed first day’s agenda with a fascinating talk about the role of a CMO in bringing products from the research lab to the market in timeefficient way. She began giving a global vision of the biopharmaceutical market and continued with a presentation on the market and technological forces that drive the biopharmaceutical industry, as well as the importance of quality by design from the first day in development.